|
[1]BELCHER JM,COCA SG,PARIKH CR.Creatinine change on vasoconstrictors as mortality surrogate in hepatorenal syndrome:systematic review&Meta-analysis[J].PLo S One,2015,10(8):e0135625.
|
|
[2]ALLEGRETTI AS,ORTIZ G,WENGER J,et al.Prognosis of acute kidney injury and hepatorenal syndrome in patients with cirrhosis:a prospective cohort study[J].Int J Nephrol,2015,2015:108139.
|
|
[3]LOW G,ALEXANDER GJ,LOMAS DJ.Hepatorenal syndrome:aetiology,diagnosis,and treatment[J].Gastroenterol Res Pract,2015,2015:207012.
|
|
[4]WONG F,NADIM MK,KELLUM JA,et al.Working party proposal for a revised classification system of renal dysfunction in patients with cirrhosis[J].Gut,2011,60(5):702-709.
|
|
[5]NADIM MK,KELLUM JA,DAVENPORT A,et al.Hepatorenal syndrome:the 8th international consensus conference of the Acute Dialysis Quality Initiative(ADQI)group[J].Crit Care,2012,16(1):r23.
|
|
[6]GINS P,SCHRIER RW.Renal failure in cirrhosis[J].N Engl J Med,2009,361(13):1279-1290.
|
|
[7]DUNDAR HZ,YILMAZLAR T.Management of hepatorenal syndrome[J].World J Nephrol,2015,4(2):277-286.
|
|
[8]WADEI HM.Hepatorenal syndrome:a critical update[J].Semin Respir Crit Care Med,2012,33(1):55-69.
|
|
[9]HAAD CR,RODRIGUEZ-BENOT A,MARTINEZ-VAQUERA S,et al.Combined liver-kidney transplantation:survey of a single center in Spain[J].Transplant Proc,2013,45(10):3640-3643.
|
|
[10]LEE JP,KWON HY,PARK JI,et al.Clinical outcomes of patients with hepatorenal syndrome after living donor liver transplantation[J].Liver Transpl,2012,18(10):1237-1244.
|
|
[11]SUSSMAN AN,BOYER TD.Management of refractory ascites and hepatorenal syndrome[J].Curr Gastroenterol Rep,2011,13(1):17-25.
|
|
[12]CHOK KS,FUNG JY,CHAN SC,et al.Outcomes of living donor liver transplantation for patients with preoperative type 1 hepatorenal syndrome and acute hepatic decompensation[J].Liver Transpl,2012,18(7):779-785.
|
|
[13]LAVAYSSIRE L,KALLAB S,CARDEAU-DESANGLES I,et al.Impact of molecular adsorbent recirculating system on renal recovery in type-1 hepatorenal syndrome patients with chronic liver failure[J].J Gastroenterol Hepatol,2013,28(6):1019-1024.
|
|
[14]HEIDEMANN J,BARTELS C,BERSSENBRGGE C,et al.Hepatorenal syndrome:outcome of response to therapy and predictors of survival[J].Gastroenterol Res Pract,2015,2015:457613.
|
|
[15]GINS P,ANGELI P,LENZ K,et al.EASL clinical practice guidelines on the management of ascites,spontaneous bacterial peritonitis,and hepatorenal syndrome in cirrhosis[J].J Hepatol,2010,53(3):397-417.
|
|
[16]KISER TH.Hepatorenal syndrome[J].Int J Clin Med,2014,5:102-110.
|
|
[17]ARROYO V,GINS P,GERBES AL,et al.Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis.International Ascites Club[J].Hepatology,1996,23(1):164-176.
|
|
[18]SALERNO F,GERBES A,GINS P,et al.Diagnosis,prevention and treatment of hepatorenal syndrome in cirrhosis[J].Gut,2007,56(9):1310-1318.
|
|
[19]FAGUNDES C,PPIN MN,GUEVARA M,et al.Urinary neutrophil gelatinase-associated lipocalin as biomarker in the differential diagnosis of impairment of kidney function in cirrhosis[J].J Hepatol,2012,57(2):267-273.
|
|
[20]VERNA EC,BROWN RS,FARRAND E,et al.Urinary neutrophil gelatinase-associated lipocalin predicts mortality and identifies acute kidney injury in cirrhosis[J].Dig Dis Sci,2012,57(9):2362-2370.
|
|
[21]FAGUNDES C,GINS P.Hepatorenal syndrome:a severe,but treatable,cause of kidney failure in cirrhosis[J].Am J Kidney Dis,2012,59(6):874-885.
|
|
[22]SOL AE,GUEVARA M,GINS P.Current treatment strategies for hepatorenal syndrome[J].Clin Liver Dis,2013,2(3):136-139.
|
|
[23]SAMPAIO MS,MARTIN P,BUNNAPRADIST S.Renal dysfunction in end-stage liver disease and post-liver transplant[J].Clin Liver Dis,2014,18(3):543-560.
|
|
[24]FABRIZI F,AGHEMO A,MESSA P.Hepatorenal syndrome and novel advances in its management[J].Kidney Blood Press Res,2013,37(6):588-601.
|
|
[25]LENZ K,BUDER R,KAPUN L,et al.Treatment and management of ascites and hepatorenal syndrome:an update[J].Therap Adv Gastroenterol,2015,8(2):83-100.
|
|
[26]ACHIM C,ZGURA,ZGURD,et al.Current therapies in hepatorenal syndrome[J].Rom J Intern Med,2014,52(4):201-215.
|
|
[27]SAGI SV,MITTAL S,KASTURI KS,et al.Terlipressin therapy for reversal of type 1 hepatorenal syndrome:a meta-analysis of randomized controlled trials[J].J Gastroenterol Hepatol,2010,25(5):880-885.
|
|
[28]GHOSH S,CHOUDHARY NS,SHARMA AK,et al.Noradrenaline vs terlipressin in the treatment of type 2 hepatorenal syndrome:a randomized pilot study[J].Liver Int,2013,33(8):1187-1193.
|
|
[29]CHOLONGITAS E,SENZOLO M,PATCH D,et al.Cirrhotics admitted to intensive care unit:the impact of acute renal failure on mortality[J].Eur J Gastroenterol Hepatol,2009,21(7):744-750.
|
|
[30]BARBANO B,SARDO L,GIGANTE A,et al.Pathophysiology,diagnosis and clinical management of hepatorenal syndrome:from classic to new drugs[J].Curr Vasc Pharmacol,2014,12(1):125-135.
|
|
[31]MELTZER J,BRENTJENS TE.Renal failure in patients with cirrhosis:hepatorenal syndrome and renal support strategies[J].Curr Opin Anaesthesiol,2010,23(2):139-144.
|
|
[32]WONG LP,BLACKLEY MP,ANDREONI KA,et al.Survival of liver transplant candidates with acute renal failure receiving renal replacement therapy[J].Kidney Int,2005,68(1):362-370.
|
|
[33]CARACENI P,SANTI L,MIRICI F,et al.Long-term treatment of hepatorenal syndrome as a bridge to liver transplantation[J].Dig Liver Dis,2011,43(3):242-245.
|
|
[34]WITZKE O,BAUMANN M,PATSCHAN D,et al.Which patients benefit from hemodialysis therapy in hepatorenal syndrome?[J].J Gastroenterol Hepatol,2004,19(12):1369-1373.
|
|
[35]BELCHER JM.Is there a role for dialysis in patients with hepatorenal syndrome who are not liver transplant candidates?[J].Semin Dial,2014,27(3):288-291.
|
|
[36]GUEUTIN V,MEFTAH A,DESBUISSONS G,et al.Hepatorenal syndrome:focus[J].Nephrol Ther,2013,9(7):471-480.
|
|
[37]CAPLING RK,BASTANI B.The clinical course of patients with type 1 hepatorenal syndrome maintained on hemodialysis[J].Ren Fail,2004,26(5):563-568.
|
|
[38]DAVENPORT A,BOUMAN C,KIRPALANI A,et al.Delivery of renal replacement therapy in acute kidney injury:what are the key issues?[J].Clin J Am Soc Nephrol,2008,3(3):869-875.
|
|
[39]BELLOMO R,CASS A,COLE L,et al.Intensity of continuous renal-replacement therapy in critically ill patients[J].N Engl J Med,2009,361(17):1627-1638.
|
|
[40]The VA/NIH Acute Renal Failure Trial Network.Intensity of renal support in critically ill patients with acute kidney injury[J].N Engl J Med,2008,359(1):7-20.
|
|
[41]WONG F.Treatment to improve acute kidney injury in cirrhosis[J].Curr Treat Options Gastroenterol,2015,13(2):235-248.
|
|
[42]GONWA TA,WADEI HM.The challenges of providing renal replacement therapy in decompensated liver cirrhosis[J].Blood Purif,2012,33(1-3):144-148.
|
|
[43]OLIVERA-MARTINEZ M,SAYLES H,VIVEKANANDAN R,et al.Hepatorenal syndrome:are we missing some prognostic factors?[J].Dig Dis Sci,2012,57(1):210-214.
|
|
[44]ELIZABETH PARSONS C,NELSON R,BOOK LS,et al.Renal replacement therapy in infants and children with hepatorenal syndrome awaiting liver transplantation:a case-control study[J].Liver Transpl,2014,20(12):1468-1474.
|
|
[45]SOURIANARAYANANE A,RAINA R,GARG G,et al.Management and outcome in hepatorenal syndrome:need for renal replacement therapy in non-transplanted patients[J].Int Urol Nephrol,2014,46(4):793-800.
|
DownLoad: